Dual block with lapatinib and trastuzumab versus single-agent trastuzumab combined with chemotherapy as neoadjuvant treatment of HER2-positive breast cancer: A meta-analysis of randomized trials

  • Matteo Clavarezza
  • , Matteo Puntoni
  • , Alessandra Gennari
  • , Laura Paleari
  • , Nicoletta Provinciali
  • , Mauro D'Amico
  • , Andrea DeCensi

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Dual block with lapatinib and trastuzumab versus single-agent trastuzumab combined with chemotherapy as neoadjuvant treatment of HER2-positive breast cancer: A meta-analysis of randomized trials'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science